Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Shuangyao Pharmaceutical Group is a comprehensive pharmaceutical enterprise based in Changchun, Jilin Province, China. The company integrates drug research and development, large-scale manufacturing, and domestic marketing, focusing on both chemical drugs and traditional Chinese medicine. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular health, respiratory conditions, and gastrointestinal disorders. The group operates multiple production lines compliant with GMP standards, producing various dosage forms including injections, tablets, and capsules. Jilin Shuangyao is recognized for its integrated business model that spans from drug synthesis to large-scale commercial distribution across the Chinese market. The company plays a significant role in the regional pharmaceutical cluster and is designated as a high-tech enterprise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Shuangyao Pharmaceutical Group.